A comprehensive review of platelet-rich plasma for the treatment of dermatologic disorders

References

• Lin M-Y, Lin C-S, Hu S, et al. Progress in the use of platelet-rich plasma in aesthetic and medical dermatology. J Clin Aesthet Dermatol. 2020;13(8):28–35.
   PubMedGoogle Scholar
• Dohan Ehrenfest DM, Andia I, Zumstein MA, et al. Classification of platelet concentrates (platelet-rich plasma-PRP, platelet-rich fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J. 2014;4(1):3–9. (1):
   PubMedGoogle Scholar
• Mercuri SR, Vollono L, Paolino G. The usefulness of platelet-rich plasma (PRP) for the treatment of vitiligo: state of the art and review. Drug Des Devel Ther. 2020;14:1749–1755.
   PubMed Web of Science ®Google Scholar
• Matras H. [Effect of various fibrin preparations on reimplantations in the rat skin]. Osterr Z Stomatol. 1970;67(9):338–359.
   PubMedGoogle Scholar
• Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(6):638–646.
   PubMed Web of Science ®Google Scholar
• Mao G, Zhang G, Fan W. Platelet-rich plasma for treating androgenic alopecia: a systematic review. Aesthetic Plast Surg. 2019;43(5):1326–1336.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Venkataraman M, Talukder M, et al. Relative efficacy of minoxidil and the 5-α reductase inhibitors in androgenetic alopecia treatment of male patients: a network meta-analysis. JAMA Dermatol. 2022;158(3):266–274.
   PubMed Web of Science ®Google Scholar
• Stevens J, Khetarpal S. Platelet-rich plasma for androgenetic alopecia: a review of the literature and proposed treatment protocol. Int J Womens Dermatol. 2019;5(1):46–51.
   PubMedGoogle Scholar
• Sasaki GH. The effects of lower vs higher cell number of platelet-rich plasma (PRP) on hair density and diameter in androgenetic alopecia (AGA): a randomized, double-blinded, placebo, parallel-group half-scalp IRB-approved study. Aesthet Surg J. 2021;41(11):NP1659–NP1672.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Hall DC, Talukder M, et al. There is a positive dose-dependent association between low-dose oral minoxidil and its efficacy for androgenetic alopecia: findings from a systematic review with meta-regression analyses. Skin Appendage Disord. 2022;8(5):355–361.
   PubMedGoogle Scholar
• Gkini M-A, Kouskoukis A-E, Tripsianis G, et al. Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period. J Cutan Aesthet Surg. 2014;7(4):213–219.
   PubMedGoogle Scholar
• Gupta AK, Cole J, Deutsch DP, et al. Platelet-rich plasma as a treatment for androgenetic alopecia. Dermatol Surg. 2019;45(10):1262–1273.
   PubMed Web of Science ®Google Scholar
• Giordano S, Romeo M, Lankinen P. Platelet-rich plasma for androgenetic alopecia: does it work? Evidence from meta analysis. J Cosmet Dermatol. 2017;16(3):374–381.
   PubMed Web of Science ®Google Scholar
• Pakhomova EE, Smirnova IO. Comparative evaluation of the clinical efficacy of PRP-Therapy, minoxidil, and their combination with immunohistochemical study of the dynamics of cell proliferation in the treatment of men with androgenetic alopecia. Int J Mol Sci. 2020;21(18):6516.
   Web of Science ®Google Scholar
• Gressenberger P, Pregartner G, Gary T, et al. Platelet-rich plasma for androgenetic alopecia treatment: a randomized placebo-controlled pilot study. Acta Derm Venereol. 2020;100(15):adv00247.
   PubMedGoogle Scholar
• Gilhar A, Etzioni A, Paus R. Alopecia areata. N Engl J Med. 2012;366(16):1515–1525.
   PubMed Web of Science ®Google Scholar
• Darwin E, Hirt PA, Fertig R, et al. Alopecia areata: review of epidemiology, clinical features, pathogenesis, and new treatment options. Int J Trichology. 2018;10(2):51–60.
   PubMedGoogle Scholar
• Strazzulla LC, Wang EHC, Avila L, et al. Alopecia areata: an appraisal of new treatment approaches and overview of current therapies. J Am Acad Dermatol. 2018;78(1):15–24.
   PubMed Web of Science ®Google Scholar
• Almohanna HM, Ahmed AA, Griggs JW, et al. Platelet-rich plasma in the treatment of alopecia areata: a review. J Investig Dermatol Symp Proc. 2020;20(1):S45–S49.
   PubMedGoogle Scholar
• Dina Y, Aguh C. Use of platelet-rich plasma in cicatricial alopecia. Dermatol Surg. 2019;45(7):979–981.
   PubMed Web of Science ®Google Scholar
• Filbrandt R, Rufaut N, Jones L, et al. Primary cicatricial alopecia: diagnosis and treatment. CMAJ. 2013;185(18):1579–1585.
   PubMed Web of Science ®Google Scholar
• Vañó-Galván S, Saceda-Corralo D, Blume-Peytavi U, et al. Frequency of the types of alopecia at twenty-two specialist hair clinics: a multicenter study. Skin Appendage Disord. 2019;5(5):309–315.
   PubMed Web of Science ®Google Scholar
• Gupta V, Parihar AS, Sharma VK, et al. Evaluation of platelet-rich plasma on hair regrowth and lesional T-cell cytokine expression in alopecia areata: a randomized observer-blinded, placebo-controlled, split-head pilot study. J Am Acad Dermatol. 2021;84(5):1321–1328.
   PubMed Web of Science ®Google Scholar
• Ragab SEM, Nassar SO, Morad HA, et al. Platelet-rich plasma in alopecia areata: intradermal injection versus topical application with transepidermal delivery via either fractional carbon dioxide laser or microneedling. Acta Dermatovenerol Alp Pannonica Adriat. 2020;29(4):169–173.
   PubMed Web of Science ®Google Scholar
• Hegde P, Relhan V, Sahoo B, et al. A randomized, placebo and active controlled, split scalp study to evaluate the efficacy of platelet-rich plasma in patchy alopecia areata of the scalp. Dermatol Ther. 2020;33(6):e14388.
   PubMed Web of Science ®Google Scholar
• Özcan D, Tunçer Vural A, Özen Ö. Platelet-rich plasma for treatment resistant frontal fibrosing alopecia: a case report. Dermatol Ther. 2019;32(5):e13072.
   PubMed Web of Science ®Google Scholar
• Bolanča Ž, Goren A, Getaldić-Švarc B, et al. Platelet-rich plasma as a novel treatment for lichen planopillaris. Dermatol Ther. 2016;29(4):233–235.
   PubMed Web of Science ®Google Scholar
• Khattab FM, Abdelbary E, Fawzi M. Evaluation of combined excimer laser and platelet-rich plasma for the treatment of nonsegmental vitiligo: a prospective comparative study. J Cosmet Dermatol. 2020;19(4):869–877.
   PubMed Web of Science ®Google Scholar
• Afify AA, Zuelfakkar NM, Eshafi MA. Fractional CO2 laser, platelet rich plasma and narrow band ultraviolet B in the treatment of vitiligo (a randomized clinical trial). Lasers Med Sci. 2021;36(7):1479–1486.
   PubMed Web of Science ®Google Scholar
• Kadry M, Tawfik A, Abdallah N, et al. Platelet-rich plasma versus combined fractional carbon dioxide laser with platelet-rich plasma in the treatment of vitiligo: a comparative study. Clin Cosmet Investig Dermatol. 2018;11:551–559.
   PubMed Web of Science ®Google Scholar
• Abdelghani R, Ahmed NA, Darwish HM. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: a prospective, randomized comparative trial. J Cosmet Dermatol. 2018;17(3):365–372.
   PubMed Web of Science ®Google Scholar
• Deng Y, Li J, Yang G. 308-nm excimer laser plus Platelet-Rich plasma for treatment of stable vitiligo: a prospective, randomized Case-Control study. Clin Cosmet Investig Dermatol. 2020;13:461–467.
   PubMed Web of Science ®Google Scholar
• Zhao L, Hu M, Xiao Q, et al. Efficacy and safety of platelet-rich plasma in melasma: a systematic review and meta-analysis. Dermatol Ther. 2021;11(5):1587–1597.
   Web of Science ®Google Scholar
• Ogbechie-Godec OA, Elbuluk N. Melasma: an up-to-date comprehensive review. Dermatol Ther. 2017;7(3):305–318.
   PubMed Web of Science ®Google Scholar
• Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol. 2011;65(4):689–697.
   PubMed Web of Science ®Google Scholar
• Qu Q, Zhou Y, Shi P, et al. Platelet-rich plasma for androgenic alopecia: a randomized, placebo-controlled, double-blind study and combined mice model experiment. J Cosmet Dermatol. 2021;20(10):3227–3235.
   PubMed Web of Science ®Google Scholar
• Mumtaz M, Chandio TH, Shahzad MK, et al. Comparing the efficacy of platelet-rich plasma (PRP) versus tranexamic acid (4mg/mL) as intradermal treatments of melasma. J Coll Physicians Surg Pak. 2021;30(5):502–505.
   PubMedGoogle Scholar
• Sthalekar B, Agarwal M, Sharma V, et al. Prospective study of growth factor concentrate therapy for treatment of melasma. Indian Dermatol Online J. 2021;12(4):549–554.
   PubMedGoogle Scholar
• Dehesa L, Tosti A. Treatment of inflammatory nail disorders. Dermatol Ther. 2012;25(6):525–534.
   PubMed Web of Science ®Google Scholar
• Jakhar D, Kaur I. Onychoscopy of nail involvement in lichen striatus. Indian Dermatol Online J. 2018;9(5):360–361.
   PubMedGoogle Scholar
• Haber JS, Chairatchaneeboon M, Rubin AI. Trachyonychia: review and update on clinical aspects, histology, and therapy. Skin Appendage Disord. 2017;2(3-4):109–115.
   PubMedGoogle Scholar
• Rehman F, Krishan K, Latif I, et al. Intra-individual right-left comparative study of combined therapy of intramatricial triamcinolone and platelet-rich plasma vs. intramatricial triamcinolone only in lichen planus-associated nail dystrophy. J Cutan Aesthet Surg. 2021;14(3):311–317.
   PubMedGoogle Scholar
• Kaur I, Jakhar D. Intramatricial platelet-rich plasma therapy: a novel treatment modality in refractory nail disorders. Dermatol Ther. 2019;32(2):e12831.
   PubMed Web of Science ®Google Scholar
• Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005;64 Suppl 2:ii18– ii 23; discussion ii24–ii25.
   PubMed Web of Science ®Google Scholar
• Florek AG, Wang CJ, Armstrong AW. Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review. Arch Dermatol Res. 2018;310(4):271–319.
   PubMed Web of Science ®Google Scholar
• Chakravdhanula U, Anbarasu K, Verma VK, et al. Clinical efficacy of platelet rich plasma in combination with methotrexate in chronic plaque psoriatic patients. Dermatol Ther. 2016;29(6):446–450.
   PubMed Web of Science ®Google Scholar
• Kauhl W, Pototschnig H, Paasch U. Can platelet-rich plasma reduce the burden of inflammatory skin diseases such as psoriasis and atopic dermatitis? Cureus. 2021;13(10):e18472.
   PubMed Web of Science ®Google Scholar
• Zhang P, Lu J, Jing Y, et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106–116.
   PubMed Web of Science ®Google Scholar
• Zahariev T, Anastassov V, Girov K, et al. Prevalence of primary chronic venous disease: the Bulgarian experience. Int Angiol. 2009;28(4):303–310.
   PubMed Web of Science ®Google Scholar
• Smith OJ, Leigh R, Kanapathy M, et al. Fat grafting and platelet-rich plasma for the treatment of diabetic foot ulcers: a feasibility-randomised controlled trial. Int Wound J. 2020;17(6):1578–1594.
   PubMed Web of Science ®Google Scholar
• Chen A, Zhang L, Chen P, et al. Comparison of the efficacy and safety of cell-assisted lipotransfer and platelet-rich plasma assisted lipotransfer: what should we expect from a systematic review with meta-analysis? Cell Transplant. 2021;30:963689721989607.
   PubMed Web of Science ®Google Scholar
• Uçar Ö, Çelik S. Comparison of platelet-rich plasma gel in the care of the pressure ulcers with the dressing with serum physiology in terms of healing process and dressing costs. Int Wound J. 2020;17(3):831–841.
   PubMed Web of Science ®Google Scholar
• Saha S, Patra AC, Gowda SP, et al. Effectiveness and safety of autologous platelet-rich plasma therapy with total contact casting versus total contact casting alone in treatment of trophic ulcer in leprosy: an observer-blind, randomized controlled trial. Indian J Dermatol Venereol Leprol. 2020;86(3):262–271.
   PubMed Web of Science ®Google Scholar
• Semenič D, Cirman T, Rožman P, et al. Regeneration of chronic wounds with allogeneic platelet gel versus hydrogel treatment: a prospective study. Acta Clin Croat. 2018;57(3):434–442.
   PubMed Web of Science ®Google Scholar
• Raposio E, Bertozzi N, Bonomini S, et al. Adipose-derived stem cells added to platelet-rich plasma for chronic skin ulcer therapy. Wounds. 2016;28(4):126–131.
   PubMed Web of Science ®Google Scholar
• Sasaki GH. A preliminary clinical trial comparing split treatments to the face and hand with autologous fat grafting and platelet-rich plasma (PRP): a 3D, IRB-approved study. Aesthet Surg J. 2019;39(6):675–686.
   PubMed Web of Science ®Google Scholar
• Mandour MF, Elsheikh MN, Khalil MF. Platelet-rich plasma fat graft versus cartilage perichondrium for repair of medium-size tympanic membrane perforations. Otolaryngol Head Neck Surg. 2019;160(1):116–121.
   PubMed Web of Science ®Google Scholar
• Nolan GS, Smith OJ, Heavey S, et al. Histological analysis of fat grafting with platelet-rich plasma for diabetic foot ulcers-a randomised controlled trial. Int Wound J. 2022;19(2):389–398.
   PubMed Web of Science ®Google Scholar
• Anzarut A, Guenther CR, Edwards DC, et al. Completely autologous platelet gel in breast reduction surgery: a blinded, randomized, controlled trial. Plast Reconstr Surg. 2007;119(4):1159–1166.
   PubMed Web of Science ®Google Scholar
• Abuaf OK, Yildiz H, Baloglu H, et al. Histologic evidence of new collagen formulation using platelet rich plasma in skin rejuvenation: a prospective controlled clinical study. Ann Dermatol. 2016;28(6):718–724.
   PubMed Web of Science ®Google Scholar
• Long T, Gupta A, Ma S, et al. Platelet-rich plasma in noninvasive procedures for atrophic acne scars: a systematic review and meta-analysis. J Cosmet Dermatol. 2020;19(4):836–844.
   PubMed Web of Science ®Google Scholar
• Gawdat HI, Tawdy AM, Hegazy RA, et al. Autologous platelet-rich plasma versus readymade growth factors in skin rejuvenation: a split face study. J Cosmet Dermatol. 2017;16(2):258–264.
   PubMed Web of Science ®Google Scholar
• Alam M, Hughart R, Champlain A, et al. Effect of Platelet-Rich plasma injection for rejuvenation of photoaged facial skin: a randomized clinical trial. JAMA Dermatol. 2018;154(12):1447–1452.
   PubMed Web of Science ®Google Scholar
• Faghihi G, Keyvan S, Asilian A, et al. Efficacy of autologous platelet-rich plasma combined with fractional ablative carbon dioxide resurfacing laser in treatment of facial atrophic acne scars: a split-face randomized clinical trial. Indian J Dermatol Venereol Leprol. 2016;82(2):162–168.
   PubMed Web of Science ®Google Scholar
• Boztug CY, Karaagac Akyol T, Benlice C, et al. Platelet-rich plasma treatment improves postoperative recovery in patients with pilonidal sinus disease: a randomized controlled clinical trial. BMC Surg. 2021;21(1):373.
   PubMed Web of Science ®Google Scholar
• Elkhouly NI, Elkilani OA, Kolaib HA, et al. Does autologous platelet-rich plasma improve wound healing and pain perception after cesarean section in high-risk patients? Gynecol Obstet Invest. 2021;86(4):336–342.
   PubMed Web of Science ®Google Scholar
• Budania A, Mandal S, Pathania YS, et al. Comparing novel versus conventional technique of platelet-rich plasma therapy in periorbital hyperpigmentation: a randomized prospective split-face study. J Cosmet Dermatol. 2021;20(10):3245–3252.
   PubMed Web of Science ®Google Scholar
• Shaik JA, Estharabadi N, Farah RS, et al. Heterogeneity in amount of growth factors secreted by platelets in platelet-rich plasma samples from alopecia patients. Exp Dermatol. 2020;29(10):1004–1011.
   PubMed Web of Science ®Google Scholar
• Poulios E, Mykoniatis I, Pyrgidis N, et al. Platelet-rich plasma (PRP) improves erectile function: a double-blind, randomized, placebo-controlled clinical trial. J Sex Med. 2021;18(5):926–935.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Bamimore M. Platelet-rich plasma monotherapies for androgenetic alopecia: a network meta-analysis and meta-regression study. J Drugs Dermatol. 2022;21(9):943–952.
   PubMed Web of Science ®Google Scholar
• Elksniņš-Finogejevs A, Vidal L, Peredistijs A. Intra-articular platelet-rich plasma vs corticosteroids in the treatment of moderate knee osteoarthritis: a single-center prospective randomized controlled study with a 1-year follow up. J Orthop Surg Res. 2020;15(1):257.
   PubMed Web of Science ®Google Scholar
• Davey MS, Hurley ET, Withers D, et al. Anterior cruciate ligament reconstruction with platelet-rich plasma: a systematic review of randomized control trials. Arthroscopy. 2020;36(4):1204–1210.
   PubMed Web of Science ®Google Scholar
• A Hamid MS, Sazlina SG. Platelet-rich plasma for rotator cuff tendinopathy: a systematic review and meta-analysis. PLoS One. 2021;16(5):e0251111.
   PubMed Web of Science ®Google Scholar
• Miron RJ, Moraschini V, Fujioka-Kobayashi M, et al. Use of platelet-rich fibrin for the treatment of periodontal intrabony defects: a systematic review and meta-analysis. Clin Oral Investig. 2021;25(5):2461–2478.
   PubMed Web of Science ®Google Scholar
• Franchini M, Cruciani M, Mengoli C, et al. The use of platelet-rich plasma in oral surgery: a systematic review and meta-analysis. Blood Transfus. 2019;17(5):357–367.
   PubMed Web of Science ®Google Scholar
• Rodrigues BL, Montalvão SAL, Cancela RBB, et al. Treatment of male pattern alopecia with platelet-rich plasma: a double-blind controlled study with analysis of platelet number and growth factor levels. J Am Acad Dermatol. 2019;80(3):694–700.
   PubMed Web of Science ®Google Scholar